VORVor Biopharma Inc.vs its industry peers
A metric-by-metric comparison of Vor Biopharma Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VORThis | $1.2B#7 | 0.1x#1 | — | — | — | -495.3%#12 | — | — | — | — | — | — |
| COAG | $1.9B#1 | — | 4.1x#7 | — | — | — | — | 0.0%#1 | — | — | — | — |
| VIR | $1.9B#2 | — | 1.9x#2 | 27.4x#5 | -7.6%#7 | 16.1%#4 | -699.2%#5 | -44.6%#6 | — | — | — | — |
| REPL | $1.7B#3 | — | 8.3x#9 | — | — | -26.9%#8 | — | -153.3%#8 | — | — | — | — |
| MAZE | $1.7B#4 | — | 3.7x#6 | 9.9x#3 | — | -351.0%#11 | -85.3%#3 | -28.9%#5 | -49.4%#1 | — | -8.8%#3 | — |
| NVAX | $1.6B#5 | — | — | 1.4x#1 | 64.7%#3 | 334.8%#1 | 40.3%#1 | — | — | — | 15.0%#2 | — |
| TSHA | $1.3B#6 | — | 3.4x#5 | 133.7x#6 | 17.3%#6 | -22.1%#7 | -1130.6%#6 | -28.1%#4 | — | — | — | — |
| INBX | $1.1B#8 | — | — | 822.6x#8 | 550.0%#1 | -108.3%#10 | -10386.5%#8 | — | — | — | -10.6%#4 | — |
| CGEM | $957M#9 | — | 2.3x#4 | — | -100.0%#8 | -31.2%#9 | — | -53.8%#7 | — | — | 71.5%#1 | — |
| ODTX | $903M#10 | — | 2.1x#3 | — | — | — | — | 0.0%#1 | — | — | — | — |
| GLUE | $897M#11 | — | 1.8x#1 | 7.3x#2 | 63.5%#4 | 46.9%#2 | -43.8%#2 | -7.9%#3 | — | — | — | — |
| MGTX | $888M#12 | 10.6x#2 | — | 10.9x#4 | 144.6%#2 | 22.7%#3 | -130.2%#4 | — | — | — | — | — |
| PRME | $808M#13 | — | 20.3x#10 | 174.4x#7 | 55.3%#5 | -2.7%#6 | -4498.1%#7 | -505.3%#10 | — | — | — | — |
| SANA | $720M#14 | — | 4.7x#8 | — | — | 8.5%#5 | — | -158.0%#9 | — | — | — | — |
| ATTO | $700M#15 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice